Boosting the Impact of SMC Through Simultaneous Screening and Treatment of Roommates

NCT04816461 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

526

Enrollment

OTHER_GOV

Sponsor class

Conditions

Malaria
Malaria Prophylaxis
Mass Testing and Treatment

Interventions

DRUG: Amodiaquine Sulfadoxine-Pyrimethamin administration
DRUG: Dihydroartemisinin-Piperaquine
DIAGNOSTIC_TEST: Standard HRP2-RDT

Sponsor

Institut de Recherche en Sciences de la Sante, Burkina Faso